Can the prophylactic quadrivalent HPV vaccine be used as a therapeutic agent in women with CIN? A randomized trial

BMC Public Health
http://bmcpublichealth.biomedcentral.com/articles
(Accessed 29 Feb 2020)

 

Can the prophylactic quadrivalent HPV vaccine be used as a therapeutic agent in women with CIN? A randomized trial
Human papillomavirus (HPV) is one of the most significant risk factors for cervical cancer. The HPV vaccine has a very significant impact on the incidence of cervical cancer. The present study aimed to investi…
Authors: Mojgan Karimi-Zarchi, Leila Allahqoli, Ameneh Nehmati, Abolfazl Mehdizadeh Kashi, Shokouh Taghipour-Zahir and Ibrahim Alkatout
Citation: BMC Public Health 2020 20:274
Content type: Research article
Published on: 27 February 2020